Home › GlaxoSmithKline's asthma drug Relvar approved in Europe
 

Keywords :   


GlaxoSmithKline's asthma drug Relvar approved in Europe

2013-11-18 15:25:07| Biotech - Topix.net

GlaxoSmithKline and Theravance's new inhaled lung drug Relvar has been approved in Europe to treat both asthma and chronic obstructive pulmonary disease , confirming an endorsement from regulators in September.

Tags: europe approved drug asthma

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10Hurricane Milton Public Advisory Number 7A
07.10Summary for Hurricane Milton (AT4/AL142024)
07.10Atlantic Tropical Weather Outlook
07.10Eastern North Pacific Tropical Weather Outlook
07.10Hurricane Milton Potential Storm Surge Flooding Map
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Hurricane Milton Graphics
07.10Hurricane Leslie Forecast Discussion Number 19
More »